CPSA Europe 2019

Meeting Programme

Updated 7 December, 2018

Tuesday | Wednesday | Thursday | Friday

Tuesday February 5

1:00 PM - 4:30 PM

The Queen's Room

WORKSHOP

1:00 PM - 4:30 PM

Magdalene Room

WORKSHOP

If Our Own Scientific Community Does Not Have the Answer Where Do We Look?

Workshop Leader: Jason Wrigley, Merck (MilliporeSigma in USA/Canada)

This workshop starts with the premise that as specialists in a particular field we are not always necessarily the best people to develop and implement novel technological approaches. As such, it will provide an overview of where we currently are with this and what we do. This will be followed by an open floor discussion to see where we could go and look for ideas and solutions. This session does not have the answers but is looking to the audience to think differently and brainstorm where we might go and look for some answers/solutions. A fun and serious discussions will be concluded with action points for follow up to see if we really can find some novel (to our industry!) solutions.

If you have a topic/area of interest you would like to include please inform us before the meeting – Think big!!

1:00 PM - 4:30 PM

The King's Room

WORKSHOP

The Future of Personalized Healthcare:
Integrated Solutions

Workshop Leader: Emily Ehrenfeld, New Objective

6:00 PM - 9:00 pm

The College Suite

Welcome Reception

Say hello to old friends and introduce yourself to new!

Wednesday February 6

7:00 AM - 8:30 AM

The Bridge Restaurant

Registration & Breakfast

8:30 AM - 9:00 AM

The University Suite

Welcome & Opening Remarks

Mike Lee

Welcome
Mike Lee
Milestone Development Services

Neil Spooner

Format, Objectives, Opening Remarks
Neil Spooner
Spooner Bioanalytical Solutions

Ismael Zamora


Ismael Zamora
Molecular Discovery

9:00 am - 10:00 am

The University Suite

Plenary Lecture

Plenary Speaker

What Solutions are Needed to Meet the Health Needs of Future Generations?

Hitesh Pandya, GlaxoSmithKline

10:00 am - 11:30 am

The University Suite

Session 1
Symposium Session

Pushing the Boundaries of Sample Collection – Near and Small

Discussion Leaders: Matt Barfield, GlaxoSmithKline; Emily Ehrenfeld, New Objective

11:45 AM - 1:15 pm

The College Suite

Sponsored Lunch & Roundtable

1:15 pm - 2:45 pm

The University Suite

Session 2
Symposium Session

Emerging Ttechnologies to Enable a Paradigm Shift from "Sick Care" to "Health Care"

Discussion Leaders: Emre Isin, UCB; Pawanbir Singh, Trajan Scientific and Medical

The primary goal for pharmaceutical industry is to develop medicines with the right exposure, reach the right target and treat the right patient. However, in the present information rich world, the ultimate objective is not only to control symptoms and treat disease but provision of technologies that facilitate both disease prevention and disease management. The enormity of this objective requires a transformative change. On one hand, there is the need to develop and have access to novel technologies which accelerate the drug development process and on the other, novel tools that enable a prevention model by focusing on forestalling disease development before clinical manifestation.

The objective of this session is to discuss emerging technologies and avenues to facilitate a paradigm shift from "sick care” to “health care"

2:45 pm - 4:15 pm

The University Suite

Workshop

Developing Novel Analytical Technologies:
Understanding the Requirements of the Patient

Workshop Leaders: Britta Bonn, AstraZeneca; Ute Gerhard, University of Hertfordshire; Emre Isin, UCB; Darragh Murnane, University of Hertfordshire

4:15 pm - 5:45 pm

The University Suite

Session 3
Symposium Session

Data in the 21st Century:  Who owns it? Who can access it?  Who pays for it? Who believes it?

Discussion Leaders: Laura Dormer, Future Science / Bioanalysis; Shane Needham, Alturas Analytics

5:45 pm

The University Suite

CPSA EUROPE GROUP PHOTO

Please gather toegther to capture the 2nd Annual CPSA Europe meeting with a group photo–including organizers, speakers, attendees–everyone!

6:00 pm - 8:00 pm

The College Suite

Reception & Dinner

Thursday February 7

7:00 AM - 8:30 AM

The Bridge Restaurant

Registration & Breakfast

8:30 am

The University Suite

Opening Remarks

Mike Lee, Milestone Development Services
Neil Spooner, Spooner Bioanalytical Solutions
Isma Zamora, Molecular Discovery

8:30 am - 10:00 am

The University Suite

Session 4
SYMPOSIUM SESSION

Moving the Needle – Intact Biomolecule Quantification

Discussion Leader: David Browne, PRA Health Sciences; Rob Buco, Waters Corporation

10:00 am - 11:30 pm

The University Suite

Session 5
Symposium Session

Using Technology to Improve Medical Adherence?

Discussion Leaders: Kevin Bateman, Merck; James Rudge, Neoteryx

The Fallacy of Adherence in Clinical Trials, and the Value of Technology as an Impartial Observer
Matt Moyer, MSD (Merck & Co. in USA/Canada)

To Be Announced
Erwin Berthier, Tasso Inc.

11:30 am - 1:00 pm

The University Suite

Sponsored Lunch & Roundtable

Patient Centric Diagnostics – From Bedside Back to Bench

How can we flip the common term "from bench to bedside" to be a more patient centric "Bedside Back to Bench"? Industry leaders will then present an overview of the current landscape. We will then open the discussion to try and find pragmatic solutions by collaboration

Introduction
Jason Wrigley, Merck

Story So Far for Cancer Diagnostics
Steven Pennington, Atturos

A Surgeon's Point of View
Nick Jenkins, Consultant Cardiovascular Surgeon

Innovative "Real Time" Decisions - Bench at the Bedside
Jenny Royle, digitalECMT

1:00 pm - 2:30 pm

The University Suite

Session 6
Symposium Session

Extraordinary Measures - Are We Measuring the Right Thing?

Discussion Leader: Ute Gerhard, University of Hertfordshire; Darragh Murnane, University of University of Hertfordshire; Christophe Stove, University of Ghent

2:30 pm - 4:00 pm

The University Suite

Workshop

How to Develop a New Product

Workshop Leaders: James Rudge, Neoteryx; Amanda Wilson, AstraZeneca

4:00 pm - 5:30 pm

The University Suite

Session 7

Symposium Session

Biomarkers – An Emerging Role in Patient Centric Drug Development

Discussion Leaders: Britta Bonn, AstraZeneca;
Axel Pähler, Roche

6:00 pm - 8:00 pm

The College Suite

Sponsored Reception & Dinner

Friday February 8

7:00 AM - 8:30 AM

The Bridge Restaurant

Registration & Breakfast

8:30 am - 9:00 am

The Peterhouse Room

Opening Remarks

Mike Lee, Milestone Development Services
Neil Spooner, Spooner Bioanalytical Solutions
Isma Zamora, Molecular Discovery

9:00 am - 10:30 am

The Peterhouse Room

Session 8
Symposium Session

Big Data Science Guiding Patient Care

Discussion Leaders: Amanda Wilson, AstraZeneca; Jason Wrigley, Merck (MilliporeSigma in USA/Canada)

10:30 am - 12:00 pm

The Peterhouse Room

Session 9
Symposium Session

To Be Announced

Discussion Leader: Ismael Zamora, Molecular Discovery

12:00 pm - 1:00 pm

The Peterhouse Room

Sponsored Lunch & Roundtable

1:00 pm - 2:30 pm

The Peterhouse Room

Session 10
Symposium Session

Current Models for Performing Quantitative Bioanalysis in Pharma and CROs – Are They Working?

Discussion Leaders: Liz Thomas, Alderley Analytical;
Neil Spooner, Spooner Bioanalytical Solutions

Pharmaceutical companies are currently wedded to outsourcing the majority of their quantitative bioanalytical work. This helps them to minimise their internal costs (capital, labour, infrastructure) and deal with the peaks and troughs in workload. For Contract Research Organisations, this would appear to be a time of feast. However, as there is so much competition in the sector and Pharma are driving costs down, the equation is not so simple. Add to this the fact that CROs need to make a profit. Does this mean that the quality vs cost equation is currently out of kilter for this process?

The session will explore the above premise through 10 min presentations from experts in the field and then look at what the solutions might be with a panel discussion.

A View from Pharma
Scott Summerfield, GlaxoSmithKline

A View from CROs
Jane Allanson, York Bioanalytical Solutions (Unilabs)

Bioanalysis 4.0: Is Automation Part of the Solution?
Nathan Hawkins, Anatune

Pharma and CRO: Could a Technology Vendor Assist in Global Harmonisation
Jason Wrigley, Merck (MilliporeSigma in USA/Canada)

3:00 pm

The Peterhouse Room

Closing Remarks

Neil Spooner, Spooner Bioanalytical Solutions
Ismael Zamora, Molecular Discovery
Mike Lee, Milestone Development Services